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ABSTRACT 
 
The immune system needs to respond to danger but remain tolerant to normal cells and tissues. 
Natural killer cells achieve tolerance to self by the use of inhibitory receptors recognizing MHC 
class I molecules on healthy cells. Only NK cells expressing such inhibitory receptors for self-
MHC class I molecules are allowed to be fully functional through a process of education. Here 
we have studied this process of education and the nature of the MHC class I mediated influence. 
We have found that MHC class I molecules exert a quantitative rather than a binary influence on 
NK cells. This means that NK cells are not “on” or “off” but also everything in-between. We 
have also found MHC class I molecules to regulate NK cells at multiple levels, such as setting 
the threshold for activation and determining the quality of NK cell responses to stimulation. 
Also the formation of the NK cell repertoire is regulated by MHC class I. We propose that this 
reflects a process in which NK cells continuously sense MHC class I and other relevant inputs 
and adapt to them. This could serve to maintain NK cell sensitivity to relative changes in stimuli 
also in a context that is highly dynamic. We have termed this the Rheostat model for NK cell 
education. 
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INTRODUCTION 
 
The immune system is a powerful and utterly complex system consisting of a myriad of 
cells, interacting via receptors and ligands and an array of soluble factors. Its cells and 
molecules circulate our bodies through both blood and lymph (1). The system is far too 
complex to be measured as a whole, using any currently available techniques. The 
immune system is therefore the only functional system lacking adequate laboratory 
tests of function and as a consequence no definitions of  “normal” human immune 
function exist (2). Studies in immunology have been dominated by the use of murine 
model systems that have provided much important knowledge to date. As novel 
experimental technologies are becoming available, a shift towards more detailed studies 
also in human subjects is ongoing (2-5). 
 
 
The evolution of immunity 
The human immune system has developed through evolution but the main purpose of 
this evolution and the relevant selective pressures governing it are not fully understood. 
It is clear that infectious diseases have placed a particularly heavy burden on human 
populations in the past, and still does in certain regions (6). This burden is exemplified 
by the fact that life expectancy of humans, before the industrial revolution was only 
around 25 years (7), largely due to infectious diseases. Obviously, such a burden of 
disease should impose a strong evolutionary pressure on humans to develop counter 
measures. Interestingly, Charles Darwin did not note the selecting pressure of 
infectious disease in his works, despite his awareness of the recent advances on the 
germ theory of disease made by his contemporaries Louis Pasteur and Robert Koch (8). 
Instead, Jack Haldane has been attributed as the first to directly describe the 
evolutionary pressure by infectious disease on human populations. His most famous 
work “Genetics and the origin of species” from 1949 contains a speculative hypothesis 
on the possible resistance to malaria by thalassemia heterozygotes (8). This idea gained 
support when Allison et al described that individuals heterozygous for the Hb-S gene of 
hemoglobin, i.e. the sickle cell trait, were protected from severe malaria infection (9, 
10). Since then, many studies have verified these findings and extended them, revealing 
the strong evolutionary pressure posed by infectious diseases on the evolution of 
human immune systems (11).  
 
 
Allogenic recognition systems 
Contrasting the idea of infectious disease as the main driving force of immune 
evolution are ideas of anti-microbial defenses as late evolutionary readjustments of a 
system initially intended for other purposes (12). The reactions to infectious pathogens 
are always examples of xenogeneic recognition while the detection of other members 
of the same species (conspecifics) represents allogeneic recognition. Some investigators 
claim that the allogenic recognition systems represent evolutionarily older modes of 
recognition and that the immune system was actually created originally to maintain 
individuality against invading cells from other members of the same species. This is 
important to prevent cells and especially genetic material from contaminating the germ-
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line and propagate to the next generation. Important support for this theory, are the 
many examples of natural chimerism described in humans and its possible links to 
disease(13-15). 
 
Compelling data from colonial marine invertebrate species such as the urochordate 
Botryllus Schlosseri shows that such primitive creatures, separated from mammalians 
about 500 million years ago, are crucially dependent on their ability to perform 
allogenic recognition (16). Botryllus Schlosseri colonies grow on natural reefs in the 
Mediterranean Sea and along the North American coastlines and are constantly facing 
the threat of predators, spatial limitation and overgrowth. These factors together 
provide survival benefit to individual zooids growing together in large colonies. Such 
colonies are formed by fusion of individual zooids (16). This fusion is regulated by an 
intricate allogeneic recognition system that have evolved to allow two proximate 
colonies either to fuse or reject each other. This response is determined by a single 
polymorphic locus where only one shared allele will lead to fusion while a mismatch 
will lead to rejection (17). 
The Fu/Hc (Fusability/Histocompatibility) locus found in the Botryllus is not a direct 
homolog of the vertebrate Major Histocompatibility (MHC) genes (18) but the 
similarities between the systems are striking. Similar self/nonself discriminatory 
systems have since been described also in other invertebrates (19) as well as in plants 
where they prevent self-fertilization (20, 21).  
 
Members of the Zipursky lab have described another interesting example of 
self/nonself discrimination at the level of an individual cell. They have described how 
growing neurons in the Drosophila brain avoid dendrite connections with its own cell 
body by using an intricate self-recognition system. In this system, individual neurons 
express alternatively spliced isoforms of the Dscam receptor and homophilic 
interactions between identical isoforms (“self-to-self”) will lead to a repulsive response 
and thus “self-avoidance”(22-24). This fascinating self-recognition system prevents 
growing neurons to form connections with its own cell body.  
 
Together these examples show that systems for allogeneic and self/nonself 
discrimination have evolved several times, and in various shapes and form throughout 
evolution in order to meet various biological requirements and to provide survival 
benefit (25). Understanding the evolutionary purpose of allogeneic recognition in 
humans is to me one of the most fascinating issues of immunology. 
 
 
Hybrid resistance 
One particular form of allogeneic recognition response of particular relevance to this 
thesis is that of “Hybrid Resistance”, HR. It was first described in 1958 by George 
Snell (26, 27) and further supported by data from Cudkowicz et al (28, 29). Hybrid 
resistance describes the ability of an F1 hybrid mouse, which is a progeny of two 
different inbred mouse strains, to reject transplanted bone marrow cells from either one, 
or both of its parental strains (30). 
 
These finding were originally controversial and in violation with the laws of 
transplantation formulated by Snell himself just a few years earlier (31). These laws 
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stated that Histocompatibility antigens were codominantly inherited and thus, no 
foreign allogenic antigens should be expressed on parental cells for the F1 hybrid 
immune system to recognize and react to (31). Such foreign antigens were believed to 
be necessary for graft rejection (31), and therefore hybrid resistance was unexpected. 
 
The molecular explanation for hybrid resistance would take decades to find and 
involved the work of many different groups. Snell himself was able to show that MHC 
related genes were important (32) and Cudkowicz showed that an unknown cell type, 
independent of the thymus but dependent on the bone marrow were responsible for this 
rejection (33). 
 
It was initially proposed that F1 hybrids were able to reject parental hematopoietic, but 
not tissue grafts (30) but more recent data have shown that also reactions to vascular 
tissue in solid organ grafts follow the rules of hybrid resistance and contribute to graft 
rejection (34). 
 
 
NK cells and the “missing self” hypothesis 
In the mid 1970ies several independent groups had described cytotoxicity against tumor 
cells by unimmunized lymphocyte populations, implying that some cell other than T 
cells contributed to target cell rejection (35). This inspired Kiessling et al at the 
Karolinska Institute and Herberman et al at the NIH, to seek and find the first 
descriptions of a population of large granular lymphocytes with a cytotoxic potential, 
distinct from cytotoxic T-cells (36-39). The cells were termed Natural Killer (NK) cells 
due to their ability to kill target cells without prior sensitization (38).  
 
The specificity of the cells was unknown and initial attempts to identify an activating 
receptor similar to the clonal receptors on T- and B-lymphocytes failed. Instead, it 
seemed clear that NK cells and T-cells used completely different modes of target 
recognition, but both involving MHC class I molecules (40).  
 
A breakthrough came in the fall of 1981 as Klas Kärre was writing his doctoral thesis. 
Inspired by the Hybrid resistance theory (30), some foreign submarines (41) and some 
data showing that some malignant cells downregulate their MHC expression during 
tumor progression (42), he proposed the “missing-self” hypothesis for NK cell 
recognition (43). His hypothesis stated that NK cells would react to the loss of MHC 
class I expression on target cells by expressing inhibitory receptors for MHC class I 
(43). A few years later the idea was experimentally supported when tumor cells lacking 
MHC class I expression was shown to be sensitive to NK cell rejection while cells of 
the same tumor cell line expressing normal levels of MHC class I was not (44). This 
fundamental idea has since formed the basis for all current theories on NK cell 
regulation by MHC class I (45). 
 
Interestingly, the concept of missing-self recognition is now a general form of innate 
immune recognition and not exclusive to NK cells. For example it applies to the 
activation of the complement cascade (1). The alternative pathway of complement 
activation is under negative regulation by several molecules such as Factor H, which is 
able to distinguish between self (host), and non-self (microbial) sialic acids. 
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Complement activation will be inhibited in the presence of self but without it 
complement activation will occur (46). 
  
Similarly, phagocytosis by macrophages is under the negative influence of self-
recognition by the inhibitory receptor Signal Regulatory Protein alpha (SIRP") (47). 
This receptor recognizes CD47 on host cells and prevents phagocytosis of “self” 
allowing phagocytosis of “missing-self”(48). Common to all these examples is that 
self-recognition provides a means of inhibiting an activating signal. Missing-self 
recognition is thereby dependent on concurrent activating signals, activating signals in 
NK cells will be discussed in more detail below.  
 
 
Variable receptors for MHC class I 
The molecular explanation to the missing-self hypothesis came when the predicted 
inhibitory NK cell receptors for MHC class I were identified. The Moretta lab 
described the Killer Immunoglobulin-like receptor (KIR) genes (49) and the Wayne 
Yokoyama lab the C-type Lectin like Ly49-receptors (50). The lectin like receptors 
(Ly49) are located in a chromosomal region termed the NK complex (NKC) while the 
Ig-like receptors are confined to the Leukocyte Receptor Complex (LRC). Together 
with the MHC class I molecules, these are the key orchestrators regulating NK cell 
biology in mammals. The MHC, NKC and LRC are located on chromosomes 6, 12 and 
19 respectively in humans. 
 
From an evolutionary point of view it is interesting to note that the variable receptor 
genes of the NKC and LRC have been selectively expanded in different ways in 
different species. In modern humans a large LRC containing 14 KIR-genes is 
responsible for MHC class I (HLA) recognition and NK cell regulation (51, 52). In 
contrast, the NKC is completely contracted and only encodes a pseudogene in humans 
(53). In mice, the situation is the opposite and the NKC includes many variable genes 
of the Ly49 family responsible for MHC class I recognition and NK cell regulation 
(53). At the same time in mice the LRC is contracted and only two KIR genes remain 
but have been moved out of the LRC onto the X chromosome (53). There are no known 
examples of species having expanded both NKC and LRC loci and the reason for why 
rodents and humans have expanded different loci since their evolutionary separation is 
not known.  
 
Most likely such selective expansion events reflect past evolutionary crises where 
expansion of a new MHC class I recognition system favored survival (54).  
 
The generally short life span of these evolving receptors throughout evolution has also 
been viewed as an indication of several competing selecting pressures. For NK cells, 
protection from microbial pathogens is clearly one such influence and the other could 
well be reproduction since NK cells play such a major role in reproductive success. 
Regulating birth weight is crucially important to humans. This is due to bipedalism and 
the narrow pelvic birth canal that comes with it (55). Therefore, strong evolutionary 
pressures influence factors regulating birth weight in humans. The placenta provides 
blood and nutrients to the fetus and its establishment through the process of 
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process where uterine NK cells play a crucial role by remodeling the maternal spiral 
arteries providing nutrients to the fetus(55, 56). This involves NK cell interactions with 
MHC class I and certain KIR-HLA compound genotypes have been linked to various 
outcomes of this process (57). 
 
Because NK cells and their variable receptors are important to both reproduction (55) 
and immunity (53) but in different ways, opposing evolutionary pressures from these 
two could explain why the variable receptor genes have been so transient through 
evolution (55). 
 
On NK cells, both KIRs in humans and Ly49 receptors in mice are clonally expressed 
in variable frequency. Receptors are expressed on NK, NKT- and some T-cells. Each 
receptor is specific for one or a few MHC class I alleles and each NK cell can express 
one or multiple of these receptors, allowing for a complex repertoire of NK cells with 
varying MHC class I specificity in a given individual (45, 58-60). Thereby the Hybrid 
resistance mystery was solved when it was shown that NK cells lacking inhibitory 
receptors specific for parental MHC class I could be responsible for the rejection of 
parental bone marrow grafts (61). Exactly how the complex NK cell receptor repertoire 
is shaped in an individual is an intense area of research and a key focus of this thesis.  
 
Another important inhibitory receptor, conserved in mice and humans, is the 
NKG2A/CD94 inhibitory receptor complex (62). This receptor binds the non-classical 
MHC class I molecule HLA-E in humans (63) and Qa-1b in the mouse (64). Qa-1b and 
HLA-E present leader peptides from classical MHC class I heavy chains, functioning 
like a survey mechanism of MHC class I transcription. The NKG2A/CD94 receptor 
complex, expressed early during NK cell development provides enough inhibitory 
signaling to prevent activation (65) but its exact relationship to the variable KIR and 
Ly49 receptors is not known. It has been proposed that NKG2A could serve as a 
“buffering” receptor for inhibitory KIR interactions with either too low, or too high 
MHC class I affinity (58, 66). This “buffering” mechanism would serve to balance the 
inhibition of NK cells, making them optimally responsive but yet self-tolerance (66). 
 
Despite the various transmembrane receptors being structurally different, their 
signaling pathways seem largely conserved (67-70). This implies evolutionary re-
application of conserved signaling complexes and modules to various types of 
receptors, possibly with different downstream effects.  
The mechanisms of inhibitory signaling from these various receptors are not fully 
understood but it seems clear that termination of activating signals occurs at multiple 
levels of the activating cascade (65, 67, 70-72). 
 
 
NK cell self tolerance and the process of education 
Since the inhibitory receptors on NK cells and their MHC class I ligands are encoded 
on different chromosomes, no genetic mechanism could ensure transcription of only 
inhibitory receptors specific for host MHC class I.  
 
In individuals lacking functional MHC class I expression, such as mice with a targeted 
mutation of !2-microglobulin (!2m) or MHC class I heavy chains (H-2Kb and Db) or 
  6
the Tap1 gene, as well as humans lacking the Tap1 gene, NK cells still exist in normal 
numbers and are tolerant to self. This despite NK cells being surrounded by MHC class 
I deficient target cells. Self-tolerance in these cases is secured by a hyporesponsive NK 
cell phenotype with an inability to kill target cells via missing-self (73, 74, 75, 117). 
We now know that also in normal individuals, NK cells exist that lack self-specific 
inhibitory receptors and display a similarly hyporesponsive and self-tolerant phenotype 
(76-78).  
 
Together, these data have led to the conclusion that NK cells will go through a process 
of education whereby only NK cells with an ability to be inhibited by self MHC class I 
will be allowed full functionality (45). Three different models have been put forward to 
explain this phenomenon. 1) The Licensing model propose a process of “licensing” in 
which NK cells with an ability to sense MHC class I gain function (79), 2) The 
Disarming model propose that NK cells are by default responsive and auto reactive 
cells unable to sense MHC class I mediated inhibition will instead be “disarmed” and 
made hyporesponsive and thereby tolerant (80). 3) The Rheostat model can be 
considered a unifying model of quantitative tuning of NK cell responsiveness where 
NK cells are more or less responsive depending on the strength of signal received from 
MHC class I in a continuous and reversible way as described further below (81). 
 
 
NK cell activation 
NK cells were named based on their ability to be triggered without prior sensitization 
(38). As such, NK cells were clearly different from T-cells. More recent studies have 
shown that in a context of an immune response NK cells do actually need a priming 
signal delivered in the lymph node in the form of trans-presented IL-15 by CD11chi 
Dendritic cells (82). Also a signal from the cytokine IL-18 seems to be able to provide 
a priming signal for NK cells to respond with IFN-# upon subsequent IL-12 stimulation 
(83). Whether these reflect absolute requirements or just a lowering of thresholds for 
activation making stimulation easier is not known. 
 
In contrast to T- and B-cells, NK cells lack clonally distributed receptors for activation. 
Instead many different receptors contribute to triggering NK cell activation through a 
complex interplay of multiple different activating signaling pathways (68). Interesting 
studies have described the interplay between activating receptors showing that 
activation of one single receptor is not enough for triggering of resting NK cells but 
instead simultaneous co-activating receptor ligation is usually needed (84, 85). One 
exception to this rule is the triggering of the Fc-receptor CD16 (Fc#RIIIb) by antibodies 
stimulating Antibody Dependent Cellular Cytotoxicity (ADCC). This form of 
activation does not require co-activation receptors (84). In general the co-activation 
theory implies that a certain threshold level of activating signal is needed to overcome 
the threshold for activation. The influences regulating the level of this threshold are still 
unknown, but its molecular wiring is being revealed (71). 
 
The ligands for activating receptors on NK cells are diverse and only partially known. 
The NKG2D receptor (86) expressed by all NK cells, #$T-cells and some CD8+ T-cells 
bind various ligands (87) upregulated upon cellular stress such as tumor transformation 
(88, 89) and DNA-damage (90). It seems increasingly clear that the induction of these 
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ligands is more complex than initially proposed. It is probable that different ligands are 
expressed in different tissues and induced by different stressors and also in a variety of 
cell types. For example skin-specific NKG2D ligands have been cloned and proposed 
to regulate wound repair (91, 92). Interesting ideas from the Hayday group have stated 
that NKG2D ligands induced in keratinocytes of the skin, recognized by local 
lymphocytes including NK cells, which could then activate dendritic cells to induce 
adaptive immunity (93). This would thus represent a novel form of immunosurveillance 
where these NKG2D ligands play a central role (93-95).  
 
Also, the importance of these ligands in viral infection is illustrated by the fact that 
Cytomegaloviruses (CMV) has developed mechanisms of targeting certain NKG2D 
ligands as way of interfering with host immune responses (96, 97). 
 
Another group of triggering receptors are the Natural Cytotoxicity receptors 
(NCRs)(98), NKp46 (99), NKp44 (100), NKp30 (101). Proposed ligand for the NKp46 
receptor is haemagglutinins of Influenza virus (102), and for NKp30 the B7-family 
member B7-H6, a ligand that seems to be expressed on tumor cells but not normal cells 
(103). Also another tumor associated molecule, BAT3 has been proposed to be a ligand 
for NKp30 suggesting that triggering of this receptor occurs upon tumor cell 
interactions (104). 
 
An interesting NK cell receptor with both activating and inhibitory signaling capacity is 
the SLAM family receptor CD244 (2B4)(105). This receptor is expressed by all NK 
cell and recognizes the CD48 receptor expressed broadly on hematopoietic cells and 
regulated in part by viral products (106). The fact that the receptor is expressed on all 
NK cells and that its ligand is abundant allow for interesting regulatory influence of this 
receptor which will be discussed in more detail below.  
 
NK cells express a vast number of additional receptors with the ability to trigger 
responses to various targets but many are still poorly understood and will not be 
described further here. 
 
 
NK cell heterogeneity 
Today, NK cells are known to be more than just “Natural Killer” cells. The population 
bearing the typical surface markers CD56 in humans and NK1.1 in the mouse, lacking 
the expression of the CD3% marker of T-cells, have proven to be a more heterogeneous 
population of cells than initially thought and with a variety of functions. 
 
NK cells are circulating both blood and lymph and are residents of most tissues in the 
body (107). They perform various functions beyond cytolysis. For example during 
pregnancy an NK cell subset, distinct from peripheral blood NK cells (108) is abundant 
in the uterus, responsible for remodeling of the spiral arteries necessary for correct 
placentation and essential for successful reproduction. The details of this process are 
still unknown but interactions with MHC class I are important. Interestingly, the only 
MHC class I allele expressed in this tissue is HLA-C and large epidemiological studies 
have shown beneficial effects of certain compound genotypes of MHC class I and their 
corresponding NK cell receptor genes with relation to reproductive success (55, 57).  
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Other interesting examples of tissue specific NK cell subsets are the mucosa-associated 
cells with similarities to NK cells. These cells are found in humans and mice and 
contribute to mucosal homeostasis and immune defenses by producing cytokines such 
as IL-22 in response to infection, regulating the epithelial homeostasis and possibly 
also providing tissue protection from inflammatory responses (109-111). Also, liver 
NK cells are interesting with a distinct phenotype and possibly able to exhibit 
immunological memory(112, 113). Similarly, our group studied pancreatic NK cells 
and found phenotypical differences to splenic NK cells, both in diabetic (NOD) and wt 
mice(114). Together it seems clear that NK cells are a heterogeneous population of 
cells widely distributed and well adjusted to its local tissue niche(107). 
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GENERAL AIMS OF THIS THESIS 
 
 
MHC class I molecules regulate NK cell activation upon target cell encounter. These 
molecules are also essential regulators of various aspects of NK cell biology. Our 
general aim has been to understand the nature of this MHC class I mediated influence. 
In this thesis I have studied the regulation of NK cell function, differentiation and 
repertoire formation by MHC class I. I have studied the quantitative influence of MHC 
class I and together with my supervisors, proposed a model for NK cell education 
termed the Rheostat model.  
 
The three articles included in this thesis represent the main focus of my work as a PhD 
student. However, a lot more work has been done with some interesting findings but 
not yet formulated into manuscripts. In the following sections of my thesis I will 
describe and discuss the results presented in the enclosed papers as well some of the 
unpublished data.  
 
In the first section I will focus on the concept of NK cell education and the various 
models proposed to explain this process. I will discuss the implications of my work 
related to the MHC class I mediated regulation of NK cell function and various aspects 
of NK cell functional regulation by MHC class I.  
 
In the second section, I will describe the findings of paper II-III on the influence of 
MHC class I expression level in target cell recognition and education and then Paper 
III extends this analysis and includes studies of the formation of the NK cell repertoire. 
This process is shown to be regulated by MHC class I can be considered yet another 
layer of regulation provided by MHC class I. 
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METHODOLOGICAL DEVELOPMENT 
 
The work presented in this thesis is based on the use of a novel reductionist 
experimental approach. It builds around various murine models with controlled 
expression of MHC class I molecules and a high-dimension flow cytometry setup 
allowing for detailed studies of very well defined NK cell populations.  
 
 
Mice with altered MHC class I expression 
The first mouse model without functional MHC class I expression was the !2-
microglobulin knock-out mouse created independently in 1989 by Rudolf Jaenisch and 
colleagues at MIT (115), and by the Smithies group at the University of North Carolina 
(116). The resulting MHC class I deficiency of all nucleated cells in these mice paved 
the way for research in the field of NK cell education by allowing studies describing 
the self-tolerance and hyporesponsiveness of !2m-/- NK cells (73, 117).  
 
Interestingly, Bieberich et al created a transgenic mouse expressing a H-2Dd transgene 
on the H-2b background (118). Using this mouse model Höglund et al were able to 
show that MHC class I directly regulates the specificity of NK cells by inducing the 
ability to reject H-2b lymphoma cells (119) as well as normal bone-marrow cells (74). 
 
For the studies described in this thesis MHC class I heavy chain knockout mice (H-2Kb-
/-Db-/-) were used as the negative control for any MHC class I influence. By crossing 
these mice to various MHC class I expressing mice, mice hemizygous for a given MHC 
class I allele were generated and back-crossed so that single MHC class I allele 
expressing mice (Homozygous) were generated (120). These mice include H-2Kb, H-
2Db, H-2Ld and H-2Dd single MHC class I allele mice. They will hereafter be denoted 
by their allelic names throughout the thesis. By using such single MHC class I allele 
expressing mice, the influence of a given MHC class I allele on NK cell function could 
be assessed (45, 120). As described in Paper II and III, we also compared the mice 
expressing a given single MHC allele in a hemi- and homozygous fashion providing a 
system to study the influence of MHC class I expression level on NK cell biology. 
 
 
Polychromatic flow cytometry 
The second aspect of our reductionist system involved a detailed characterization of the 
expression of MHC class I specific receptors. This was required since NK cells often 
express multiple receptors with varying, and often overlapping, specificity for MHC 
class I alleles. Our desire to understand the outcome of individual Receptor-Ligand 
interactions therefore urged us to develop an advanced flow cytometry protocol 
involving the simultaneous detection of 6-7 inhibitory receptors for MHC class I on 
individual NK cells. This tedious exercise involved testing of multiple antibody-
flourochrome combinations as well as staining protocols before finally being 
established. Together with the surface receptor detection parameters, we also include 
markers for NK cells, viable cells, forward and side-scatter parameters as well as 2-3 
functional parameters resulting in a flow cytometry protocol of 13-15 parameters in 
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total. For efficient and standardized analysis of such large data sets we developed 
gating algorithms based on Boolean-statistics using the software suite FlowJo 
(Threestar, California U.S). 
 
 
Single cell activation assays 
Another important technological advancement important to our studies is the recent 
development of assays based on flow cytometry for the functional assessment of 
individual NK cells. These assays are performed in vitro where an activating stimulus 
such as a target cell or a plate bound antibody to an activating NK cell receptor, is 
present. NK cells will respond with upregulation of activation markers such as the 
CD69 antigen (121). They will also, depending on the stimulus respond by secreting 
cytokines such as IFN-# and chemokines into the supernatant. The amount of cytokine 
or chemokine secreted by individual NK cells can now be directly quantified by the 
addition of a chemical inhibitor of exocytosis such as Brefeldin A (122). Another 
important advancement allowing for single-cell measurement of function was the 
identification of the marker CD107a/Lamp1 found in the membrane of vesicles 
secreted from cells, such as the cytotoxic granules on cytotoxic T- and NK cells (123). 
By using this antibody during stimulation of NK cells, the amount of cytotoxic 
responses by individual cells can be estimated from the amount of CD107a staining. 
Such staining is dependent on the release of cytotoxic granules, exposing the antibody 
labeling epitope leading to antibody binding. This important technical advancement has 
been instrumental to the work of this thesis allowing the assessment of function of 
individual NK cells rather than population oriented assays of function. 
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RESULTS AND DISCUSSION  
 
Discussion on the models of NK cell education 
When I started working in the laboratory of Klas Kärre and Petter Höglund, the field of 
NK cell education was focused on the most recent results by Wayne Yokoyama and 
David Raulet showing the existence of NK cells in normal mice, lacking the expression 
of self-specific inhibitory receptors for MHC class I. These cells were shown to be self-
tolerant due to a hyporesponsive phenotype similar to the one of MHC class I deficient 
NK cells described above. These results supported the notion that hyporesponsiveness 
is induced or maintained through NK cell education in order to secure self-tolerance 
and that this occurs even in normal mice and not just in the artificial setting of MHC 
class I deficiency (76, 77). Similar observations were also made in normal human 
subjects (78).  
 
Two seemingly conflicting models were proposed to describe the functional 
development of NK cells under the influence of MHC class I mediated signals. Firstly, 
the “Licensing model” proposed that NK cells are non-functional or hyporesponsive by 
default and only acquire functional competence or “a license to kill” upon MHC class I 
mediated signals during development (76, 79). In contrast to this, Raulet et al proposed 
a “Disarming” model in which NK cells are considered functionally responsive by 
default but would be “disarmed” in the absence of MHC class I mediated inhibition 
during development (77, 80). 
 
Initially it seemed contra-intuitive that signals from inhibitory receptors would transmit 
a “positive” signal inducing “licensing” as proposed by the Yokoyama model (76). 
Also, Raulet and colleagues claimed that the “Disarming model” was more compatible 
with older experimental data (80). The licensing model seemed to predict that NK cell 
interactions with surrounding cells lacking MHC class I, i.e. missing-self targets, would 
not be relevant to NK cell licensing.  
 
This fact seemed incompatible with data from Wu et al who created Bone-Marrow 
chimeras between MHC class I negative and MHC class I-positive bone marrow cells. 
In these chimeric mice tolerance to MHC deficient cells was dominantly induced by the 
presence of MHC class I deficient cells in the chimera. Also data from our own group 
showed similar results when a Dd-transgene introduced in a H-2b mouse model 
accidently was expressed in a mosaic fashion on 20-80% of cells. Also in these DL6 
mice, tolerance to Dd-negative target cells was dominantly induced by the presence of 
Dd-negative cells (124). Again, this result suggested that NK cell education and the 
development of self-tolerance to co-existing missing-self targets depends on 
interactions with such targets and would possibly be more compatible with the 
disarming model of NK cell education (80). 
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As another test of our prediction that NK cell education is quantitatively determined by 
the strength of MHC class I mediated input, we tested the responsiveness of NK cells 
expressing single and multiple Ly49-receptors specific for self-MHC class I. The 
reasoning was that NK cells expressing multiple receptors would receive more MHC 
class I mediated signal and thus be more responsive than cells expressing only one 
receptor. As shown in Paper I, Fig. 6, combinations of Ly49/NKG2A receptors did 
provide synergistic effects on NK cell responsiveness as measured by the amount of 
degranulation supporting the idea that NK cell responsiveness is dependent on the 
strength of inhibitory input during NK cell education. These data were later supported 
by data from Joncker et al also showing synergistic effects of co-expressed inhibitory 
receptors on NK cell responsiveness (125). A study from the Parham group on human 
NK cells provided support for quantitative NK cell education in humans by showing 
that NK cells expressing multiple self-specific KIR receptors responded more strongly 
to missing-self target cells than did single KIR expressing cells (66). These data again 
suggest that NK cell education in both mice and humans is quantitatively regulated by 
the signals from MHC class I. 
 
All tests described above compared NK cells educated via different MHC class I 
interactions involving multiple receptors or MHC alleles making it impossible to 
exclude that differences between different Ly49-MHC interactions would not account 
for the differences seen. We therefor sought to develop a system where the MHC class 
I ligand-receptor interactions would be qualitatively similar but quantitatively different. 
Based on this we crossed our single MHC class I mice to MHC-/- mice to generate 
MHC hemizygous mice. In these mice the cell surface expression levels of MHC class I 
molecules Kb, Db and Dd were heavily reduced (Paper II, Fig. 1 and Paper III, Fig. 
1A). For the Dd allele the reduction was about 50% percent (Paper III, Fig. 1A), 
providing an optimal system to dissect quantitative NK cell education by allowing us to 
study the consequences of interactions between a given Ly49 receptor and its MHC 
class I ligand expressed at either a high, or a lower level.  
 
As shown in Paper III, Fig. 1B, when inoculating MHC deficient cells into Dd+/- and 
Dd+/+ mice respectively, we saw a striking difference in global NK cell mediated 
rejection of MHC class I deficient target cells. NK cells educated by a Dd-ligand 
expressed at a high surface level (Dd+/+) rejected the target cells twice as efficiently as 
Dd+/- NK cells over time. These data imply that NK cells are sensitive to the expression 
level of its MHC class I ligands during education and that during this quantitative 
process, the ability of the NK cell system to reject missing-self targets is set 
proportional to its MHC class I input signals. 
 
 
Differences between differently responsive NK cells 
After seeing the quantitative differences at the population level, we sought to 
understand whether these differences between NK cell populations educated in the 
context of a high educating impact, as compared to a lower educating impact would, be 
reflected by changes at the level of the individual NK cell. The higher level of missing-
self reactivity in vivo in mice with a higher educating impact could in theory be 
explained by 1) a higher frequency of educated NK cells responding to target cells, 2) a 
stronger response by the cells responding or, 3) a combination of both. To delineate 
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these effects, we stimulated NK cells from these various mice in vitro and measured 
single cell responsiveness by flow cytometry.  
 
We found that a high educating impact, such as the presence of multiple MHC class I 
alleles or one strong vs. one weak MHC class I allele, led to a higher frequency of NK 
cells responsive to a given activating stimuli (Paper I, Figs. 2, 3 and 4). Also Dd+/+, as 
compared to Dd+/- NK cells, made more NK cells responsive to stimulation with 
antibody mediated cross-linking of activating receptor NKp46 (Paper III, Figs. 1C). 
Combined these results suggested that NK cell education quantitatively regulates the 
frequency of NK cells responsive to a given activating stimulus. It also suggests that 
the more efficient missing-self rejection in mice with a high educating impact could be 
explained, at least in part by a higher frequency of NK cells responding to the target 
cells in these mice (Paper I and III).  
 
We also measured the quality of the responses elicited by these different NK cell 
populations. We measured the Mean Fluorescence Intensity (MFI) of cytokines 
produced and the simultaneous release of both cytotoxic granules and cytokines and in 
some cases, chemokines.  
 
The rationale for this approach came from recent data on T-cells. Studies had shown 
that the per cell amount of cytokine produced by a given T-cell, as measured by the 
MFI of that cytokine, positively correlated with the ability of the T-cell to 
simultaneously produce complex responses, called polyfunctionality (126). This 
involved a simultaneous production of different cytokines or chemokines and the 
release of cytotoxic granules (127). It was also proposed that such polyfunctionality 
represented a higher quality of T-cell response as compared to a more simple response 
(128, 129). One study had also shown that the presence of polyfunctional T-cell clones 
correlated with a better clinical outcome of Leishmania Major infection (127, 130). 
Also, a study on human NK cells suggested a qualitative difference in responses to 
Influenza A virus infected target cells. This differences was suggested to be linked to 
differences in MHC class I mediated NK cell education (131). 
 
We therefor tested the quality of responses produced by NK cells subsets educated in 
the context of a high and a low educating impact. We found that upon stimulation of 
activating NK cell receptors using cross-linking antibodies, NK cells from mice 
expressing multiple as compared to a single MHC class I allele, one strong vs. a weak 
allele or one given allele in a homo- as compared to a hemizygous fashion, all 
responded with more cytokine or chemokine on a per cell basis as measured as MFI for 
the given parameter upon intracellular staining (Paper I, Fig. 5, Paper III, Fig. S1C). 
Also, the frequency of NK cells displaying polyfunctionality as simultaneous cytokine 
and cytotoxicity (Paper I, Fig. 5) and chemokine secretion (Paper III, Fig. 1C). These 
data suggests that NK cell education, not only determines the frequency of cells 
responding to a given stimuli, but also the quality of responses produced by these NK 
cells. Our data together with the data on qualitative responses in T-cells, suggests that 
polyfunctionality is a common feature of highly efficient lymphocyte populations.  
 
The molecular regulation of polyfunctionality is currently unknown. One interesting 
clue comes from an experimental setting of T-cell receptor (TCR) gene transfer and the 
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When we injected MHC class I hemizygous splenocytes into mice expressing the same 
MHC class I alleles but in a homozygous fashion, no rejection was seen over 4 days of 
follow-up. This clearly show that a 50% reduction of MHC class I expression on 
normal healthy cells does not trigger missing-self rejection in vivo (Paper II, Fig. 2A-
C). To test if we could break this tolerance by inducing a higher state of general 
immune activation in vivo, we pretreated the recipient mice with the Type I Interferon 
inducer Tilorone (Sigma-Aldrich, Stockholm). This drug acts as an Interferon inducer 
when administered orally (138) and stimulates NK cells to be more responsive to target 
cells and to cytokine stimulation. Despite pre-activation NK cells were still completely 
tolerant to inoculated cells expressing half their level of MHC class I, Paper II, Fig. 
2D. From these results we conclude that NK cell tolerance is robust and a loss of more 
than 50% of MHC class I expression is required to trigger missing-self rejection, even 
if NK cells are pre-activated by interferon signals in vivo. 
 
Next we tried to investigate NK cell rejection of splenocytes expressing even less MHC 
class I on their cell surface. We developed a systems using cells lacking functional the 
peptide transporter Tap1, necessary for transport of cytosolic peptides into the 
Endoplasmic reticulum (ER) where MHC class I processing and assembly occurs (139, 
140). In such cells, the empty MHC class I complexes assemble and reach the cell 
surface but are instable and rapidly fall apart (141). Addition of peptides in the 
extracellular fluid can stabilize MHC class I expression if the peptides bind and 
stabilize these empty MHC complexes (142). We took advantage of this and incubated 
Tap1-/- splenocytes with a stabilizing peptide in a titrated range of concentrations to 
induce various levels of surface expression of MHC class I. We were able to stabilize a 
surface expression level of the MHC class I allele Kb between 10-80% of the surface 
level in Kb homozygous mice. When these target cells were inoculated into Kb+/+ mice, 
all cells expressing a level of Kb at 20% or more of Kb+/+ recipients were tolerated while 
cells expressing less than that were rejected, Paper II, Fig. 3. 
 
We conclude from this that there seems to be a threshold for activation in NK cells and 
that this threshold is robustly calibrated to maintain tolerance to normal cells expressing 
a wide range of MHC class I. It is highly possible that cells expressing more ligands for 
activating receptors, such as tumor cells or virally infected cells, upregulating stress 
ligands etc. would trigger NK cell activation more easily than the normal splenocytes 
used in this study. A different pattern has previously been described in a study 
measuring tumor cell rejection by human NK cells. It was found that B-lymphoblastoid 
tumor cells transfected with MHC class I molecules were protected from NK cell 
killing and that protection was quantitative and positively correlated with the amount of 
MHC class I expression on the transfected cells (143). There was therefor a discrepancy 
to our data on normal target cells showing more of a threshold effect on NK cell 
resistance. One possible explanation for this discrepancy is the abundance of ligands 
for activating NK cell receptors presumably present on these B-lymphoblastoid cells. 
Such ligands would probably provide a much stronger activating signal than the healthy 
splenocytes used in our experiments. Thus, in the presence of abundant activating 
signals NK cells are more likely to respond and the response becomes quantitatively 
correlated with the amount of MHC class I expressed. It was also shown in this study 
that MHC class I transfected tumor cells were only protected from naïve but not 
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FIGURE 4 illustrates our interpretation of our data on a quantitative MHC class I 
influence at the cellular, population and organism level respectively (81). We propose 
that individual NK cells adapt their level of responsiveness to the strength of MHC 
class I mediated inhibitory signals during education. We believe, the purpose of this 
would be to secure robust tolerance to self by only allowing cells able to sense 
inhibition from MHC class I to be fully responsive. However, this does not explain the 
quantitative nature of the process of education. Tolerance does not in theory at least, 
require a quantitative process of education but should be achieved also by a binary 
process where cells able to sense adequate inhibition only would be allowed any 
responsiveness, i.e. “a license to kill”. Instead, our data clearly show that the NK cell 
education system is quantitative.  
 
Could there be a possible selective benefit of having a NK cell population made up of 
more or less potent cells?  
One possible reason might be that it is an important feature for the system to be able to 
call in more potent killers in the event of a more serious challenge. This means that 
having highly efficient cells around is a valuable feature for the systems. However, 
such highly potent cells would need to be kept tightly regulated to prevent 
autoreactivity, and this could in theory be achieved by allowing NK cells to balance 
their responsiveness to their inhibitory signal. In this way the most potent killers will 
also be most tightly regulated, i.e. having the highest threshold for activation due to the 
expression of multiple inhibitory receptors for MHC class I. In this way the NK cell 
population includes cells with different responsiveness and a level of regulation that is 
proportional to this in order to maintain self-tolerance. 
 
Although this idea is highly speculative it could be tested experimentally. So far we 
have mainly tested responsiveness of individual NK cells using antibody-mediated 
cross-linking of activating receptors. This form of stimulation bypasses the inhibitory 
receptors completely and will only test the potency of the activating signaling pathway 
itself. If NK cell subsets were instead triggered by a target cell expressing some MHC 
class I but also enough ligands for activating receptors to override this inhibition and 
trigger the NK cells, one could test whether NK cells expressing only one inhibitory 
receptor would be more likely to respond as compared to NK cells expressing multiple 
receptors specific for the MHC class I molecules on the target cells. One could also test 
the prediction that the cells expressing multiple receptors and still do respond, would 
respond more potently than NK cells expressing only single receptors. This would be 
predicted from our data on NK cells triggered using antibody mediated cross-linking of 
activating receptors, Paper I, Fig. 6. 
 
 
Reversible and continuous tuning of responsiveness 
Our Rheostat model of tuning of activation thresholds could reconcile the two previous 
and contradictory models of NK cell education, the “Licensing”(76, 79) and 
“Disarming”(77, 80) models. Bidirectional tuning of NK cell thresholds for activation 
could serve to increase (“Licensing”) and reduce responsiveness (“Disarming”) as a 
continuously active process of adaptation, FIGURE 5(81). We propose that NK cell 
education is in fact such a continuous process of adaptation rather than just a process 
limited to NK cell development and maturation. In this way, NK cell tuning of 
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Activation induced tuning of NK cell responsiveness 
Several studies have described reduced NK cell responsiveness upon continuous 
stimulation. Non-obese diabetic (NOD) mice (153) display an NK cell defect, which 
has partly been explained by a reduced expression level and dethatched signaling 
pathway of the activating receptor NKG2D, possibly due to continuous ligand 
stimulation in vivo (154). Also when NK cells are co-cultured with ligand expressing 
tumor cells in vitro there is a gradual loss of function of the NKG2D receptor over time 
(155). Whether these findings reflected a tuning of global NK cell responsiveness or 
just an isolated defect in one overstimulated pathway was not clear at this point.  
 
However, when Oppenheim et al expressed the NKG2D ligand Rae1% as a transgene, 
either in squamous epithelium or broadly in all tissues, broader NK cell defects were 
shown. The rejection of b2m-/- cells in vivo was impaired in mice expressing Rae1% 
broadly but interestingly enough, even more impaired in mice expressing this NKG2D 
ligand in squamous epithelia only. This suggests that NK cell responsiveness was tuned 
down as NK cells interacted with Rae1e expressing cells, a tuning that could be 
reversed by global NK cell activation using the TLR3-ligand Poly I:C (156). This 
defect is probably not due to a direct role for NKG2D since NKG2D-/- mice exhibit 
normal missing-self reactivity (157). Instead this suggests that prolonged stimulation 
via NKG2D leads to a reduced responsiveness to other stimuli. Supporting this, 
Coudert et al incubated NK cells with tumor cells transfected with another murine 
NKG2D ligand H60 and found that this led to a markedly reduced responsiveness to 
various different stimuli including RMA/S cells, i.e. missing-self targets (158). 
 
In line with these data on NKG2D engagement, Sun et al and Tripathy et al published 
independent reports of mice expressing the viral glycoprotein m157, a ligand for the 
activating Ly49H receptor in H-2b mice. Also this led to the impairment of Ly49H 
signaling and in some cases to broader NK cell defects involving other activating 
receptor stimuli (159). It also suggested an inability of NK cells to proliferate and 
expand in the context of a viral infection (160), suggesting that tuning mechanisms also 
influences such features. 
 
 
Tuning and cellular adaptation in biology 
Many different cell types use an adaptation or tuning ability to be able to respond to 
relative changes in their surrounding, rather than absolute levels of signals or ligands. 
This adaptation must be determined by continuous input and therefor not only 
influenced by the same input that is strong enough to trigger full activation of cells. 
Previous triggering events would not provide current information on the current 
contextual environment of the cell. Instead more continuous interactions are needed.  
 
It has been widely discussed by Grossman and Paul (161-164) that T-cells might adapt 
to their surrounding by sub-threshold stimulation of their antigen receptor by self-
antigens. This input from self-antigens would be too weak to cause full activation but 
still allow for continuous tuning of the activation threshold. In this way, T-cell anergy 
has been proposed to be a result of a tuning event where the threshold for activation has 
been tuned very high due to the sudden strong stimulus in the absence of co-stimulation 
(164). Also, thymic selection has been proposed to represent a process of tuning where 
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T-cells need to tune up their responsiveness slowly as they pass through the stages of 
selection to be allowed to exit into the periphery (165). 
 
Similarly, nerve cells stimulated by light will adapt to a prolonged stimulation in order 
to maintain sensitivity to subsequent alterations in light stimuli (166). This is what 
happens when we enter a dark room. At first we are blind but after a few seconds of 
adaptation, our visual system is adapted to the lower level of background stimulation 
and we are able to discriminate contours if there is only a little bit of light present. 
 
We believe that similar adaptation processes occur in NK cells. Our hypothesis does 
not only imply input from MHC class I as the tuning input even though that has been 
the focus of our studies. Instead, all possible stimuli that NK cells can sense and 
respond to, would be expected to cause tuning. This includes cytokines such as IL-15, 
necessary for proliferation and survival of NK cells as well as inputs from various 
activating receptors. We believe that the tuning could occur for all these inputs either as 
an integrated net input signal that would induce one master tuning process of 
adaptation, or possibly as individual inputs separately cause tuning of their respective 
signaling pathway with individual adaptive circuits connected to them. 
 
The idea of adaptation in signal transduction pathways is well established. It can be 
accomplished by combinations of various feedback and feed-forward loops where 
protein molecules and transduction pathways can act as computational elements in 
living cells (167). 
 
 
The murine NK cell repertoire 
From the discussions above it is clear that the actions of NK cells are highly determined 
by the MHC class I specific receptors they express. These receptors determine 
specificity and responsiveness of NK cells through interactions of its MHC class I 
ligands. The composition of the NK cell repertoire in an individual is thus a key 
determinant of global NK cell mediated function. As illustrated by Hybrid resistance 
described above, a variable NK cell repertoire where NK cells express different 
combinations of receptors is a prerequisite for allogeneic recognition of partially MHC 
mismatched cells and not only MHC class I deficient cells (168). 
 
Whether there exist mechanisms regulating the formation of this NK cell repertoire or 
not has been a matter of debate for years. Held et al found in 1996 that NK cells 
expressing two inhibitory receptors for an MHC class I allele were less frequent in mice 
expressing that allele than in other mice (169). This have since been confirmed by 
others (59, 170-172). Also in Ly49A-transgenic mice expressing the Dd ligand for this 
receptor, the frequency of cells expressing another Dd specific receptor Ly49G2 was 
reduced (173). 
 
Ly49 receptor genes are assumed to be stably expressed once turned on. This is based 
on data where sorted Ly49+ cells were transferred and followed over 10 days without 
any observed changes in Ly49 expression (174). Based on this assumption and the data 
above two developmental schemes were proposed by Raulet et al. First, the sequential 
expression model proposes that every developing NK cell expresses individual 
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receptors in a cumulative way but in random order. At the same time interactions with 
MHC class I occur and as soon as the NK cell senses adequate inhibitory signal it will 
continue to mature with a stable Ly49 expression (168). The second model is a two step 
selection model in which NK cells with a stochastic Ly49 expression will be tested first 
for its ability to bind MHC class I and secondly that this binding is not too strong (168). 
In a recent analysis using mathematical modeling of these two processes fitted to 
experimental data from multiple MHC class I transgenic mice, we found that the two-
step selection fit the experimental data better than the sequential acquisition model (59). 
It was also shown that an open parameter in the simulations improved fit in many 
instances suggesting that additional mechanisms would contribute to the shaping of the 
repertoire. Such mechanisms could involve influence on subset proliferation and/or 
survival. 
 
Our high dimension flow cytometry protocol allows for the first time for full 
characterization of the near complete Ly49/NKG2A repertoires from MHC class I 
deficient and sufficient mice. In Paper III we present our data and model for the 
shaping of the NK cell repertoire in mice. To focus on quantitative MHC class I effects 
we use the Dd-/-, Dd+/- and Dd+/+ model system whereby we can measure the influence of 
a given, well-characterized MHC class I allele on NK cell repertoire formation. When 
we stained individually for the 4 Ly49 receptors and NKG2A, measuring the 
frequencies of all 32 possible NK cell subsets a pattern was clear. Our results show that 
NK cell subsets expressing multiple receptors (3-5) are less frequent as compared to 
MHC class I deficient mice while the opposite is true for NK cells expressing 1 or 2 
receptors, Paper III, Fig. 2.  
 
To investigate a possible mechanism for this pattern we studied population dynamics of 
NK cell subsets and found that the frequency of pre-apoptotic cells at a given time in 
the spleen of the different mice correlated with the selection patterns, Paper III, Fig. 3. 
As this suggested that there might be a link between population survival, turnover and 
possibly proliferation and selection we decided to study this further. We found that NK 
cells positively selected were more responsive to IL-15 stimulation, proliferated more 
at limiting concentration of IL-15 in vitro and had a regulated expression level of the 
proapototic factor bim upon cytokine deprival, Paper III, Fig. 4.  
 
We conclude from these data that there seems to be a link between MHC class I 
interactions, the formation of the NK cell repertoire and the sensitivity of NK cells to 
IL-15.  
 
Future work should focus on establishing the molecular link between these different 
signaling pathways central to NK cell biology. Cross-regulation between the IL-15 
signaling pathway and the NKG2D activating receptor pathway have recently been 
proposed. Horng et al disrupted the NKG2D pathway by directly targeting the adaptor 
DAP10 for ubiquitination. This made NK cells unresponsive to NKG2D stimuli but 
also to IL-15 (175). It is theoretically possible that the necessary tuning signal 
supporting NK cell function and survival to regulate function and repertoire formation 
is a complex signal of several simultaneous interactions. NK cell priming in the lymph 
node during an immune response requires the trans-presentation of IL-15 by dendritic 
cells (82). Trans-presentation of cytokines in contrast to signals from soluble cytokines 
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have been proposed to serve the purpose of giving context dependent signals, that is 
allowing for cytokine stimulation in conjunction with other simultaneous signals.  
 
My hypothesis would thus be that NK cell interactions with dendritic cells trans-
presenting IL-15 could provide the unique signaling context needed for NK cell tuning. 
If MHC class I interactions and possibly a third signal from NKG2D or other receptors 
occur simultaneously with IL-15 in this unique context of interaction, a different 
downstream signal could result as compared to when these stimuli are given separately. 
This in turn could provide the tuning signal and the adjustment of thresholds for 
activation, cytokine sensitivity etc.  
 
 
NK cell repertoires in mice and men 
The role of MHC class I in shaping the murine NK cell repertoire is well established 
even if the details of this process still remain unclear.  
 
The repertoire of Killer Immunoglobulin-like Receptors (KIRs) in humans have been 
challenging to study due to the variation between individuals as a consequence of 
genetic variations excluded from the inbred laboratory mouse for which population 
genetics is largely ignored. Despite the difficulties, several groups have provided high-
resolution data on NK cell repertoires in humans with interesting patterns (58, 60, 66, 
176-178). It is not yet clear whether a MHC class I dependent mechanism shaping the 
KIR repertoire exists or not, some data suggest this.  
 
To understand this better ongoing analysis by us in collaboration with the Malmberg, 
Uhrberg, Parham and Mehr groups will hopefully bring some clarity to this issue. We 
are working to reanalyze all generated data on human KIR repertoires and murine Ly49 
repertoires in relation to MHC class I using comparable methods of calculation. In 
doing so we hope to find common and disparate patterns for future study. Using the 
increased power of calculations we hope to be able to settle the issue of MHC class I 
mediated control of the KIR repertoire in humans. Preliminary results confirm the 
expected pattern that interindividual variability is significantly greater in human data 
sets as compared to the murine data (Simon et al manuscript in preparation). 
 
 
Non-MHC class I signals in the formation of the NK cell repertoire 
NK cells are surrounded by cells expressing MHC class I and these molecules will 
continuously be ligated by NK cells, possibly providing continuous tuning input 
regulating both function and repertoire formation. Also, other abundant molecules 
could also in theory influence NK cells similarly.  
 
CD244 (2B4) is a receptor expressed on all NK cells recognizing the CD2 family 
receptor CD48 expressed abundantly on most hematopoietic cells. Thus, NK cells 
could in theory be surrounded by cells expressing ligands for 2B4 and continuous 
interactions with such cells could contribute and possibly influence the continuous 
signals from MHC class I. As shown in FIGURE 8, we found that the Ly49 receptor 
repertoire in 2B4-/- mice follow the same pattern as a 2B4+/+ (B6) mouse, as expected 
from the fact that they share the same MHC class I expression (H-2b). The pattern of 
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Hyporesponsive NK cells can only be defined by functional tests. A surface marker 
would be highly useful to better characterize molecular differences between differently 
responsive NK cells. Hyporesponsive NK cells share some similarities with anergic T-
cells and specific surface markers have been described for anergic T-cells (181). We 
therefor tested the expression of surface markers CD98, 4-IBBL and FasL (181) 
without finding any significant differences between MHC-deficient and wt NK cells 
(Data not shown). 
 
Instead the best marker for NK cell responsiveness seems to be the inhibitory surface 
receptor Killer-cell lectin-like receptor G1 (KLRG1)(182) expressed at a higher level 
on educated than MHC-deficient NK cells (151, 183) and also quantitatively regulated 
in correlation with NK cell responsiveness on Dd+/- and Dd+/+ NK cells, Paper III, Fig. 
S2. KLRG1 has been shown to be associated with a senescent T-cell phenotype (182, 
184) but its function is still unclear. Its presumed ligands are cadherin family members. 
Interestingly, KLRG1 k.o mice exhibit normal responses to Lymphocytic 
choriomeningitis virus (LCMV) and MCMV, but also normal RMA/S rejection and 
IFN-# responses to antibody mediated cross-linking of the activating NK1.1 receptor on 
NK cells (185). One study showed that NK cells on free-living, wild mice express 
higher levels of KLRG1, possibly suggesting a role for external influences on KLRG1 
expression, such as infections not occurring in laboratory mice (186). 
 
Clearly more work is needed before any mechanism of NK cell education can be 
described. The potential for using the KLRG1 surface marker to sort out cells with 
different MHC class I experience is very encouraging and should inspire more 
advances towards this end. 
 
 
Cis-interaction between Ly49 receptors and MHC class I in tuning of NK cell 
responsiveness 
It is well established that NK cells can interact with MHC class I both in trans on other 
cells as well as in cis where MHC class I ligands are expressed on the NK cell itself 
(187-189). The importance of the cis-interaction has been elusive but in a recent study 
Held et al have proposed a possible role for cis-interaction in regulating quantitatively 
NK cell responsiveness (190). The model was inspired by data showing how the ITIM-
containing receptor CD22, a negative regulator of B-cell receptor (BCR) signaling 
(191), is in turn regulated by cis-interacting sialic acids in the B-cell membrane (192, 
193). In normal situations most CD22 molecules are located in clusters distant from the 
BCR complex, unable to inhibit B-cell activation. These clusters are maintained by cis-
interaction with sialic acids regulating the number of CD22 molecules in proximity of 
the BCR with a potential to inhibit activating signals is regulated (192). 
 
Translating this to NK cells, Chalifour et al showed that cis-interactions between MHC 
class I and Ly49 receptors in the NK cell membrane serve to sequester Ly49 receptors 
away from the activating synapse where triggering occurs (190). Unengaged Ly49 
receptors were able, by unknown mechanism to inhibit NK cell activation when 
accessing the synapse, even without ligating MHC class I on target cells (190). The 
model suggests that NK cells can quantitatively regulate their responsiveness by 
regulating the amount free or unengaged (in cis) Ly49 receptors (190).  
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CONCLUDING REMARKS 
 
In this thesis and over the years of work we have realized several important features of 
the MHC class I mediated regulation of NK cells. Firstly, the influence is clearly 
quantitative rather than binary meaning that NK cells are never either or, on or off but 
always everywhere in-between. 
 
Also the influence of MHC class I affect multiple aspects of NK cell biology, from 
thresholds to activation, quality of responses to the shaping of the NK cell repertoire. 
We have proposed a theoretical model in which all these processes reflect a process of 
adaptation in the NK cell system to its current context. We have suggested this to be a 
continuously ongoing process of adaptation similar to other adaptive processes 
described in biology and that such adaptation is important for NK cells to remain 
sensitive to challenges even in a context that is always changing. Maybe similar 
processes of adaptation are continuously ongoing in all cells of the immune system and 
the body as a whole and maybe our ideas of NK cells will add a little piece to that 
never-ending puzzle of wonder that is biology. 
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